HUMAN DISEASE MODELED by npas4l^{Df(Chr13:lycat)m39/m39}
No data available

GENE EXPRESSION
Gene expression in npas4l^{Df(Chr13:lycat)m39/m39}

PHENOTYPE
Phenotype in npas4l^{Df(Chr13:lycat)m39/m39}

Phenotype	Conditions	Figures
blood island tfec expression absent, abnormal	standard conditions	Fig. 1 from Mahony et al., 2016
blood island gata1a expression absent, abnormal	standard conditions	Fig. 1 from Mahony et al., 2016
blood vasculature morphology, abnormal	standard conditions	Fig. S2 from Herpers et al., 2008
blood vessel morphogenesis disrupted, abnormal	standard conditions	Fig. S2 from Herpers et al., 2008
cell aging magnitude, normal	standard conditions	Fig. 3  from Kishi et al., 2008
endocardium development disrupted, abnormal	standard conditions	Fig. 1  from Wong et al., 2012
eye decreased size, abnormal	standard conditions	Fig. 1  from Posner et al., 2019
eye lens opaque, abnormal	standard conditions	Fig. 1 from Zou et al., 2015
fin regeneration occurrence, normal	standard conditions	Fig. 6  from Yoshinari et al., 2009
heart shape, abnormal	standard conditions	Fig. 1  from Posner et al., 2019
hematopoietic system jak2a expression absent, abnormal	control	Table 1 from Oates et al., 1999
intermediate cell mass of mesoderm jak2a expression absent, abnormal	control	Fig. 6 from Oates et al., 1999
intermediate cell mass of mesoderm etsrp expression decreased amount, abnormal	standard conditions	Fig. S4 from Reischauer et al., 2016
intermediate cell mass of mesoderm hbae1.1 expression decreased amount, abnormal	control	Fig. 6 from Oates et al., 1999
intermediate cell mass of mesoderm gata1a expression decreased amount, abnormal	standard conditions	Fig. S4 from Reischauer et al., 2016 Fig. 6 from Oates et al., 1999
intermediate cell mass of mesoderm hbbe3 expression decreased amount, abnormal	control	Fig. 6 from Oates et al., 1999
intermediate cell mass of mesoderm tal1 expression decreased amount, abnormal	standard conditions	Fig. S4 from Reischauer et al., 2016 Fig. 6,  Fig. 7 from Oates et al., 1999
intermediate cell mass of mesoderm gata1a expression decreased distribution, abnormal	standard conditions	Fig. S4 from Reischauer et al., 2016
intermediate cell mass of mesoderm etsrp expression decreased distribution, abnormal	standard conditions	Fig. S4 from Reischauer et al., 2016
intermediate cell mass of mesoderm tal1 expression decreased distribution, abnormal	standard conditions	Fig. S4 from Reischauer et al., 2016
intermediate cell mass of mesoderm decreased size, abnormal	standard conditions	Fig. S4 from Reischauer et al., 2016
lateral plate mesoderm tal1 expression absent, abnormal	control	Fig. 7 from Oates et al., 1999
lens decreased diameter, abnormal	standard conditions	Fig. 2  from Posner et al., 2019
lens enucleation decreased occurrence, abnormal	standard conditions	Fig. 6 from Wu et al., 2016
lens fiber cell nucleus increased amount, abnormal	standard conditions	Fig. 3  from Posner et al., 2019
neurohypophysis has normal numbers of parts of type neurosecretory neuron axon terminus, normal	standard conditions	Fig. 5  from Gutnick et al., 2011
neurohypophysis lacks all parts of type blood vasculature, abnormal	standard conditions	Fig. 5  from Gutnick et al., 2011
nucleate erythrocyte absent, abnormal	standard conditions	Fig. 1  from Posner et al., 2019
pericardium edematous, abnormal	standard conditions	Fig. 1  from Posner et al., 2019 Fig. S2 from Herpers et al., 2008
posterior lateral plate mesoderm bif1.1 expression absent, abnormal	standard conditions	Fig. 1  from Ghersi et al., 2019
posterior lateral plate mesoderm bif1.2 expression decreased amount, abnormal	standard conditions	Fig. S8  from Ghersi et al., 2019
posterior lateral plate mesoderm physical object quality, abnormal	standard conditions	Fig. S1  from Novikov et al., 2013
trunk bent, abnormal	standard conditions	Fig. 1  from Posner et al., 2019
whole organism lacks all parts of type endothelial cell, abnormal	standard conditions	Fig. S3 from Zhou et al., 2011